Results of Annual General Meeting

RNS Number : 1871O

Advanced Medical Solutions Grp PLC

08 June 2022

 

8 June 2022

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Results of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies , announces that at the Company's Annual General Meeting held today at 11 am at the Offices of Investec Bank plc, 30 Gresham Street, London, EC2V 7QP, all resolutions were duly passed.Further details of each of the resolutions are set out in the Notice of Meeting, which was sent to shareholders on 29 April 2022.

The poll results were as follows.

Resolution	Title	For (see note 2)		Against (see note 2)
		No. of shares	%	No. of shares	%
1	Receive Annual Report and Accounts	122,189,273	99.99	2,000	0.01
2	Approve the Remuneration Report	121,168,966	99.02	1,198,956	0.98
3	Re-appoint Deloitte LLP as auditors	116,797,783	95.92	4,969,411	4.08
4	Re-elect Peter Allen	103,388,287	89.10	12,651,027	10.90
5	Re-elect Grahame Cook	113,183,101	92.49	9,190,030	7.51
6	Elect Douglas Le Fort	115,464,984	99.27	844,330	0.73
7	Re-elect Chris Meredith	120,304,522	98.31	2,068,609	1.69
8	Re-elect Eddie Johnson	122,028,446	99.72	344,685	0.28
9	Declare final dividend	122,378,935	99.99	1,121	0.01
10	Authorise allotment of shares	117,948,199	96.38	4,430,807	3.62
11	Disapply pre-emption rights*	108,025,798	88.28	14,345,022	11.72
12	Authorise purchase of own shares*	94,316,659	99.05	907,369	0.95

*  Special Resolution

Notes: 1.  Votes "For" and "Against" are expressed as a percentage of votes received. 2.  A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution. 3.  Total number of shares in issue at close of business on 6 June = 216,626,583 shares. 56% of the voting capital was instructed.

- Ends -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Matthew Neal / Matthew Cole	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Daniel Adams / Gary Clarence
HSBC Bank PLC (Broker)	Tel: [phone]
Sam McLennan / Joe Weaving / Stephanie Cornish

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand^®, RESORBA^®, LiquiBandFix8^® and Seal-G^®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal^® brand as well as under white label. Since 2019, the Group has made four acquisitions: Sealantis, an Israeli medical device company with a patent-protected sealant technology platform; Biomatlante, an established French developer and manufacturer of innovative surgical biomaterial technologies, Raleigh, a UK leading coater and converter of materials predominately for woundcare and bio-diagnostics products and AFS Medical, a specialist distributor of minimally invasive surgical devices based in Austria .

AMS's products, manufactured in the UK, Germany, France, the Netherlands, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Germany, France and Israel. Established in 1991, the Group has more than 700 employees. For more information, please see www.admedsol.com .

 

END

 

 

RAGFLFSFRDITIIF